Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
The Journal of Experimental Medicine|March 1, 1996
Expansion of cytokine-producing CD4-CD8- T cells associated with abnormal Fas expression and hypereosinophiliaH U Simon, S Yousefi, C C Dommann-Scherrer, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 1, 1995
Short-term weekly chemotherapy followed by high-dose therapy with autologous bone marrow transplantation for lymphoblastic and Burkitt's lymphomas in adult patientsL M Jost, E Jacky, C Dommann-Scherrer, et al.
Archives of Dermatological Research|April 1, 1996
Clonal disease in extracutaneous compartments in cutaneous T-cell lymphomas. A comparative study between cutaneous T-cell lymphomas and pseudo lymphomasS N Dommann, C C Dommann-Scherrer, M T Dours-Zimmermann, et al.
The American Journal of Dermatopathology|August 1, 1997
Expression of intercellular adhesion molecule 3 (CDw50) on endothelial cells in cutaneous lymphomas. A comparative study between nodal and cutaneous lymphomasS N Dommann, C C Dommann-Scherrer, T Ziegler, et al.
International Journal of Cancer|November 11, 1993
Epstein-Barr virus subtype distribution in angioimmunoblastic lymphadenopathyB Borisch, M Caioni, N Hurwitz, et al.
Virchows Archiv : an International Journal of Pathology|January 1, 1995
Occult hepatosplenic T-gamma delta lymphoma. Value of genotypic analysis in the differential diagnosisC C Dommann-Scherrer, S B Kurer, D R Zimmermann, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 1, 1992
Chemotherapy with MACOP-B and VACOP-B for intermediate- and high-grade non-Hodgkin's lymphoma: clinical results and analysis of prognostic factorsG Pichert, J Peters, R A Stahel, et al.
British Journal of Haematology|April 7, 1999
A prospective study of risk-adapted therapy for large cell non-Hodgkin's lymphoma with VACOP-B followed by high-dose CBV and autologous progenitor cell transplantation for high-risk patients in remissionR A Stahel, L M Jost, T Kroner, et al.
The British Journal of Dermatology|December 20, 2018
Interferon alfa-2a maintenance after salvage autologous stem cell transplantation in atypical mycosis fungoides with central nervous system involvementM Doerschner, A Pekar-Lukacs, O Messerli-Odermatt, et al.
Cancer Science|March 1, 2008
MAGE-C1/CT-7 expression in plasma cell myeloma: sub-cellular localization impacts on clinical outcomeM Tinguely, B Jenni, A Knights, et al.
Pageof 2